The University of South Florida Sarasota–Manatee is a branch campus of the University of South Florida in Sarasota, Florida.

During the past decade, University of South Florida - Bradenton conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of South Florida - Bradenton" are "Multiple Sclerosis, Relapsing-Remitting" (2 trials). Many other conditions were trialed in "University of South Florida - Bradenton" in a lesser frequency.

Most popular intervention types in "University of South Florida - Bradenton" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of South Florida - Bradenton" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of South Florida - Bradenton". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of South Florida - Bradenton, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of South Florida - Bradenton, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".